APO Research, Inc.

APO RESEARCH · REPORT

Adenosylcobalamin Tablets

Selected research

Market Structure

Global Adenosylcobalamin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Adenosylcobalamin Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Adenosylcobalamin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Adenosylcobalamin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adenosylcobalamin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Adenosylcobalamin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adenosylcobalamin Tablets include Fujian Gutian Pharmaceutical Co., Ltd., Sinopharm Group Rongsheng Pharmaceutical Co., Ltd., Hebei Bianque Pharmaceutical Co., Ltd., North China Pharmaceutical Co., Ltd., North China Pharmaceutical Hebei Huanuo Co., Ltd., Ningxia Zhouyang Pharmaceutical Co., Ltd., Shijiazhuang Kangli Pharmaceutical Co., Ltd. and Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Adenosylcobalamin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Adenosylcobalamin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Adenosylcobalamin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Adenosylcobalamin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Adenosylcobalamin Tablets Segment by Company

Fujian Gutian Pharmaceutical Co., Ltd.

Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.

Hebei Bianque Pharmaceutical Co., Ltd.

North China Pharmaceutical Co., Ltd.

North China Pharmaceutical Hebei Huanuo Co., Ltd.

Ningxia Zhouyang Pharmaceutical Co., Ltd.

Shijiazhuang Kangli Pharmaceutical Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Adenosylcobalamin Tablets Segment by Type

Boxed

Bottled

Adenosylcobalamin Tablets Segment by Application

Hospital

Clinic

Other

Adenosylcobalamin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adenosylcobalamin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adenosylcobalamin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adenosylcobalamin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Adenosylcobalamin Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adenosylcobalamin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Adenosylcobalamin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Adenosylcobalamin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Adenosylcobalamin Tablets Industry Trends Table 2. Adenosylcobalamin Tablets Industry Drivers Table 3. Adenosylcobalamin Tablets Industry Opportunities and Challenges Table 4. Adenosylcobalamin Tablets Industry Restraints Table 5. Global Adenosylcobalamin Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Adenosylcobalamin Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Adenosylcobalamin Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Adenosylcobalamin Tablets Sales Market Share by Manufacturers Table 9. Global Adenosylcobalamin Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Adenosylcobalamin Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Adenosylcobalamin Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Adenosylcobalamin Tablets Manufacturers, Product Type & Application Table 13. Global Adenosylcobalamin Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Adenosylcobalamin Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Boxed Table 17. Major Manufacturers of Bottled Table 18. Global Adenosylcobalamin Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Adenosylcobalamin Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Adenosylcobalamin Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Adenosylcobalamin Tablets Sales Market Share by Type (2021-2026) Table 22. Global Adenosylcobalamin Tablets Sales Market Share by Type (2027-2032) Table 23. Global Adenosylcobalamin Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Adenosylcobalamin Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Adenosylcobalamin Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Adenosylcobalamin Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Adenosylcobalamin Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Adenosylcobalamin Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Adenosylcobalamin Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Adenosylcobalamin Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Adenosylcobalamin Tablets Sales Market Share by Application (2021-2026) Table 35. Global Adenosylcobalamin Tablets Sales Market Share by Application (2027-2032) Table 36. Global Adenosylcobalamin Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Adenosylcobalamin Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Adenosylcobalamin Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Adenosylcobalamin Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Adenosylcobalamin Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Adenosylcobalamin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Adenosylcobalamin Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Adenosylcobalamin Tablets Sales Market Share by Region (2021-2026) Table 44. Global Adenosylcobalamin Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Adenosylcobalamin Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Adenosylcobalamin Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Adenosylcobalamin Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Adenosylcobalamin Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Adenosylcobalamin Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Adenosylcobalamin Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Adenosylcobalamin Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Adenosylcobalamin Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Adenosylcobalamin Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Adenosylcobalamin Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Adenosylcobalamin Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Adenosylcobalamin Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Adenosylcobalamin Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Adenosylcobalamin Tablets Revenue Market Share by Region (2027-2032) Table 63. Fujian Gutian Pharmaceutical Co., Ltd. Company Information Table 64. Fujian Gutian Pharmaceutical Co., Ltd. Business Overview Table 65. Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 67. Fujian Gutian Pharmaceutical Co., Ltd. Recent Development Table 68. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Company Information Table 69. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Business Overview Table 70. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 72. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Recent Development Table 73. Hebei Bianque Pharmaceutical Co., Ltd. Company Information Table 74. Hebei Bianque Pharmaceutical Co., Ltd. Business Overview Table 75. Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 77. Hebei Bianque Pharmaceutical Co., Ltd. Recent Development Table 78. North China Pharmaceutical Co., Ltd. Company Information Table 79. North China Pharmaceutical Co., Ltd. Business Overview Table 80. North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 82. North China Pharmaceutical Co., Ltd. Recent Development Table 83. North China Pharmaceutical Hebei Huanuo Co., Ltd. Company Information Table 84. North China Pharmaceutical Hebei Huanuo Co., Ltd. Business Overview Table 85. North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 87. North China Pharmaceutical Hebei Huanuo Co., Ltd. Recent Development Table 88. Ningxia Zhouyang Pharmaceutical Co., Ltd. Company Information Table 89. Ningxia Zhouyang Pharmaceutical Co., Ltd. Business Overview Table 90. Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 92. Ningxia Zhouyang Pharmaceutical Co., Ltd. Recent Development Table 93. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Company Information Table 94. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Business Overview Table 95. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 97. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Recent Development Table 98. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 99. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 100. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio Table 102. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Adenosylcobalamin Tablets Distributors List Table 106. Adenosylcobalamin Tablets Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Adenosylcobalamin Tablets Product Image Figure 2. Global Adenosylcobalamin Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adenosylcobalamin Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Adenosylcobalamin Tablets Sales (2021-2032) & (K Units) Figure 5. Global Adenosylcobalamin Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Adenosylcobalamin Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Boxed Image Figure 9. Bottled Image Figure 10. Global Adenosylcobalamin Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Adenosylcobalamin Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Adenosylcobalamin Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Adenosylcobalamin Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Adenosylcobalamin Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Adenosylcobalamin Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Adenosylcobalamin Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Adenosylcobalamin Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Adenosylcobalamin Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Adenosylcobalamin Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Adenosylcobalamin Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Adenosylcobalamin Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Adenosylcobalamin Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Adenosylcobalamin Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Adenosylcobalamin Tablets Sales Market Share by Country (2021-2032) Figure 39. China Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Adenosylcobalamin Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Adenosylcobalamin Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Adenosylcobalamin Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Adenosylcobalamin Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Adenosylcobalamin Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Adenosylcobalamin Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Adenosylcobalamin Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Adenosylcobalamin Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Adenosylcobalamin Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Adenosylcobalamin Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Boxed
  • Bottled
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Fujian Gutian Pharmaceutical Co., Ltd.
  • Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
  • Hebei Bianque Pharmaceutical Co., Ltd.
  • North China Pharmaceutical Co., Ltd.
  • North China Pharmaceutical Hebei Huanuo Co., Ltd.
  • Ningxia Zhouyang Pharmaceutical Co., Ltd.
  • Shijiazhuang Kangli Pharmaceutical Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Adenosylcobalamin Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Adenosylcobalamin Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Adenosylcobalamin Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Adenosylcobalamin Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Adenosylcobalamin Tablets Market Dynamics
  1. 2.1 Adenosylcobalamin Tablets Industry Trends
  2. 2.2 Adenosylcobalamin Tablets Industry Drivers
  3. 2.3 Adenosylcobalamin Tablets Industry Opportunities and Challenges
  4. 2.4 Adenosylcobalamin Tablets Industry Restraints
3 Adenosylcobalamin Tablets Market by Manufacturers
  1. 3.1 Global Adenosylcobalamin Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Adenosylcobalamin Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Adenosylcobalamin Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Adenosylcobalamin Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adenosylcobalamin Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Adenosylcobalamin Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Adenosylcobalamin Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adenosylcobalamin Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adenosylcobalamin Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adenosylcobalamin Tablets Tier 1, Tier 2, and Tier 3
4 Adenosylcobalamin Tablets Market by Type
  1. 4.1 Adenosylcobalamin Tablets Type Introduction
  2. 4.1.1 Boxed
  3. 4.1.2 Bottled
  4. 4.2 Global Adenosylcobalamin Tablets Sales by Type
  5. 4.2.1 Global Adenosylcobalamin Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Adenosylcobalamin Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Adenosylcobalamin Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Adenosylcobalamin Tablets Revenue by Type
  9. 4.3.1 Global Adenosylcobalamin Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Adenosylcobalamin Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Adenosylcobalamin Tablets Revenue Market Share by Type (2021-2032)
5 Adenosylcobalamin Tablets Market by Application
  1. 5.1 Adenosylcobalamin Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Adenosylcobalamin Tablets Sales by Application
  6. 5.2.1 Global Adenosylcobalamin Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Adenosylcobalamin Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Adenosylcobalamin Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Adenosylcobalamin Tablets Revenue by Application
  10. 5.3.1 Global Adenosylcobalamin Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Adenosylcobalamin Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Adenosylcobalamin Tablets Revenue Market Share by Application (2021-2032)
6 Global Adenosylcobalamin Tablets Sales by Region
  1. 6.1 Global Adenosylcobalamin Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Adenosylcobalamin Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Adenosylcobalamin Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Adenosylcobalamin Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Adenosylcobalamin Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Adenosylcobalamin Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Adenosylcobalamin Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Adenosylcobalamin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Adenosylcobalamin Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Adenosylcobalamin Tablets Revenue by Region
  1. 7.1 Global Adenosylcobalamin Tablets Revenue by Region
  2. 7.1.1 Global Adenosylcobalamin Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Adenosylcobalamin Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Adenosylcobalamin Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Adenosylcobalamin Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Adenosylcobalamin Tablets Revenue (2021-2032)
  8. 7.2.2 North America Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Adenosylcobalamin Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Adenosylcobalamin Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Adenosylcobalamin Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Adenosylcobalamin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Fujian Gutian Pharmaceutical Co., Ltd.
  2. 8.1.1 Fujian Gutian Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Fujian Gutian Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  6. 8.1.5 Fujian Gutian Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
  8. 8.2.1 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  12. 8.2.5 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Hebei Bianque Pharmaceutical Co., Ltd.
  14. 8.3.1 Hebei Bianque Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Hebei Bianque Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  18. 8.3.5 Hebei Bianque Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 North China Pharmaceutical Co., Ltd.
  20. 8.4.1 North China Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 North China Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  24. 8.4.5 North China Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 North China Pharmaceutical Hebei Huanuo Co., Ltd.
  26. 8.5.1 North China Pharmaceutical Hebei Huanuo Co., Ltd. Company Information
  27. 8.5.2 North China Pharmaceutical Hebei Huanuo Co., Ltd. Business Overview
  28. 8.5.3 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  30. 8.5.5 North China Pharmaceutical Hebei Huanuo Co., Ltd. Recent Developments
  31. 8.6 Ningxia Zhouyang Pharmaceutical Co., Ltd.
  32. 8.6.1 Ningxia Zhouyang Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Ningxia Zhouyang Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  36. 8.6.5 Ningxia Zhouyang Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shijiazhuang Kangli Pharmaceutical Co., Ltd.
  38. 8.7.1 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  42. 8.7.5 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  44. 8.8.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
  48. 8.8.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Adenosylcobalamin Tablets Value Chain Analysis
  2. 9.1.1 Adenosylcobalamin Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Adenosylcobalamin Tablets Production Mode & Process
  6. 9.2 Adenosylcobalamin Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Adenosylcobalamin Tablets Distributors
  9. 9.2.3 Adenosylcobalamin Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.